Myc Proto-Oncogene Protein (MYC) Antibody

Este producto es parte de MYC proto-oncogene, bHLH transcription factor
Myc Proto-Oncogene Protein (MYC) Antibody
169€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Myc Proto-Oncogene Protein (MYC) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx318489
Tested Applications
ELISA, WB, IHC

Description

MYC Antibody is a Rabbit Polyclonal against MYC.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Myc Proto-Oncogene Protein (MYC)
Immunogen: Recombinant human Myc proto-oncogene protein (1-439AA).
Host
Rabbit
Reactivity
Human, Mouse
Recommended Dilution
WB: 1/500 - 1/5000, IHC: 1/20 - 1/200. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Purity
> 95%
Purification
Purified by Protein G.
Size 1
20 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
1 mg
Form
Liquid
Tested Applications
ELISA, WB, IHC
Buffer
0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P01106
Gene ID
4609
NCBI Accession
NP_002458.2, NM_002467.4
OMIM
113970
Alias
MRTL,MYCC,c-Myc,bHLHe39,Transcription factor p64,Proto-oncogene c-Myc,Class E basic helix-loop-helix protein 39
Background
Antibody anti-MYC
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

The MYC proto-oncogene encodes a basic helix-loop-helix (bHLH) transcription factor that is central to regulating cell growth, proliferation, and metabolism. It acts as a master regulator by binding to E-box sequences within the genome to control the transcription of numerous genes involved in key cellular processes, such as ribosome biogenesis, cell cycle progression, and apoptosis. Dysregulation of MYC, often through overexpression or amplification, is a hallmark of many cancers, including Burkitt lymphoma and various solid tumors. This dysregulation promotes uncontrolled cell proliferation and impairs apoptosis, contributing to tumorigenesis. Additionally, MYC interacts with multiple co-factors and chromatin-modifying complexes, further amplifying its impact on the epigenetic landscape. Given its critical role in oncogenesis, MYC is extensively studied as a therapeutic target, with ongoing efforts to develop strategies to inhibit its activity or downstream pathways to treat MYC-driven malignancies. Its widespread effects on cellular physiology underscore its importance in both normal development and disease.

Productos relacionados

abx000153

MYC (pT58) Antibody

MYC (pT58) Antibody is a Rabbit Polyclonal antibody against MYC (pT58). The protein encoded by this gene is a multifunct…

Ver producto
abx000155

MYC (pS62) Antibody

MYC (pS62) Antibody is a Rabbit Polyclonal antibody against MYC (pS62). The protein encoded by this gene is a multifunct…

Ver producto
abx000184

MYC (pS373) Antibody

MYC (pS373) Antibody is a Rabbit Polyclonal antibody against MYC (pS373). The protein encoded by this gene is a multifun…

Ver producto